Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Long-Term Investments (2020 - 2025)

Celularity (CELU) has disclosed Long-Term Investments for 3 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Investments changed N/A to $2.9 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.9 million, a N/A change, with the full-year FY2020 number at $291.8 million, changed N/A from a year prior.
  • Long-Term Investments was $2.9 million for Q3 2025 at Celularity, down from $128.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $291.8 million in Q1 2021 to a low of $2.9 million in Q3 2025.